[142]
In this context, a skilled person, seeing the 1982 Gerster abstract (or poster) would not say "I can apply this to ofloxacin!" and obtain the same increase in activity. In the absence of such an exclamation, a skilled person would not have an endpoint in mind (i.e., levofloxacin), and would not attempt to experiment with existing processes, including the Gerster 1982 process, to resolve ofloxacin into its enantiomers, disregarding the extent of experimentation required to adapt such processes to ofloxacin.
Beneficial properties of levofloxacin are surprising and unexpected